Overview

Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Twenty-four week, prospective, randomized, double-blind, placebo-controlled, parallel-group study.
Phase:
Phase 3
Details
Lead Sponsor:
Eisai Inc.
Treatments:
Donepezil